Abstract
Cytokines are a group of diverse molecules that influence the function of every organ system. They are most well studied in their effects on the immune system and their integral role in mediating inflammation. The common cold and otitis media are two such disease states, and much has been learned about the various effects of cytokines in each disease. Most often the viruses isolated include rhinovirus (RV), respiratory syncytial virus (RSV), adenovirus, coronavirus, and picornavirus. Otitis media, sinusitis, bronchiolitis, pneumonia, and asthma exacerbation are commonly accepted as complications of viral upper respiratory tract infections. Furthermore, otitis media and upper respiratory infections are inextricably linked in that the majority (>70 %) of cases of acute otitis media occur as complications of the common cold. Cytokine polymorphisms have been associated with the severity of colds as well as the frequency of otitis media. This article attempts to update the reader on various studies that have recently been published regarding the role of cytokines in these two disease entities.
Keywords: Cytokine, Cytokine response, Otitis media, Common cold, Viral upper respiratory infection, Stress, Viral signaling pathways, Inflammatory response, Inner ear inflammation, Ion transport
Introduction
The common cold is a viral upper respiratory infection (vURI) that is caused by a number of different viruses such as rhinovirus, adenovirus, coronavirus, enterovirus, influenza virus, parainfluenza virus, and respiratory syncytial virus (RSV) [1, 2]. Within the last decade, human bocavirus and human metapneumonvirus have been discovered and identified in middle ear effusions [3–5]. The degree of illness seen with an individual vURTI differs substantially, and a certain proportion of vURI can exist without causing a cold-like illness (CLI). Furthermore, complications of vURI (otitis media, sinusitis, acute bronchiolitis, pneumonia, and exacerbations of various respiratory illnesses including asthma and chronic obstructive pulmonary disease) can occur without CLI [6]. Thus, discussing the common cold can be done by analyzing studies of vURIs.
vURIs are a leading cause of health-care utilization. According to 2000 US census data, approximately 110 million physician visits, 23.2 million physician phone calls, and 6 million emergency department visits were attributable to vURIs [7]. Excluding asthma exacerbations, it was estimated that vURIs resulted in health-care expenditures approximating 40 billion dollars [7].
Otitis media can be an acute or chronic inflammatory condition involving the middle ear and mastoid. Otitis media is multifactorial with many variables affecting its outcome including environmental exposures, genetic characteristics, and infections. Specifically, acute otitis media occurs at least once in 80 % of children under the age of 3 and is the most common cause of antibiotic prescription in children [8, 9]. Otitis media is considered a complication of vURI, and otitis media is associated with preceding vURI in more than 70 % of cases [6].
Cytokines consist of a diverse group of molecules that allow intercellular communication. Cytokines are central to the inflammatory response and tissue remodeling. They have effects on a wide variety of organ systems and are implicated in numerous disease processes such as vURIs and the common cold. In this review, we explore the recent literature regarding cytokine responses secondary to the common cold and otitis media and their interactions.
Cytokine Responses and the Common Cold
Cytokines’ role in vURI is significant and appears to have importance in the variability of disease symptomatology. This is supported by greater nasal cytokine concentrations during vURIs versus disease-free periods [10–12], vURIs with CLIs versus vURIs without CLIs [13], and vURIs with airway complications [14–16]. Additionally, cytokine polymorphisms can be associated with increased susceptibility to vURTI, as seen with IL-6-174 [17]. Disease severity also appears to correlate with cytokine polymorphisms, as seen with respiratory syncytial virus infections in 77 children [18]. Recently, Broers et al. supported this by reporting on an ex vivo study comparing cytokine response to influenza A virus exposure in children with trisomy 21 and in their siblings [19•]. They found that TNF-α, IL-1β, IL-6, and IL-8 were significantly higher in children with Down syndrome versus controls. Furthermore, they identified that baseline and post-viral levels of IFN-α and IFN-γ were significantly elevated. This suggests that in addition to having neurological impairment, cardiopulmonary defects, and abnormal upper airway anatomy, the innate cytokine response likely has an important role in increased disease severity with viral respiratory illness in Down syndrome patients and may even correlate with complications of vURIs, such as otitis media.
Cytokine Production in the Common Cold and Stress
It is commonly accepted that psychological stress increases the risk of many medical problems, including upper respiratory infections, poor wound healing, diabetes, and autoimmune and cardiovascular diseases [20]. Historically, this association has been attributed to dysregulation of the hypothalamic-pituitary-adrenocortical access. Cohen et al. recently reported their unique study assessing chronic stress, glucocorticoid receptor resistance, inflammation, and risk of developing a cold when subjects were exposed to rhinovirus [21••]. They showed that circulating levels of cortisol did not predict risk of cold, but that glucocorticoid resistance predicts an increased risk of cold. Perhaps more importantly, glucocorticoid receptor resistance correlated with increased IL-6 and TNF-α, but not with IL-1β. Overall, this study supports the notion that induction of proinflammatory cytokines does not upregulate immunity, but may actually correlate to increased risk of infection.
Viral Signaling Pathways and Effect on Cytokines
Viruses infect host cells and depend on certain molecular processes present in host cells that allow replication. Host cells recognize this invasion, and protective mechanisms, both innate and learned, exist to fight these organisms. During influenza infection, activation of NF kappa B and the Raf/MEK/ERK cascade is critical to viral replication. Specifically, inhibition of the Raf/MEK/ERK cascade and NF kappa B impaired both viral replication and the production of IL-8, MCP-1, IL-6, RANTES, IFN-β, and TNF-α in recent in vitro and in vivo models [22•]. The idea that an inhibitor can be used to affect viral replication and cytokine production is an ideal therapeutic model. Such therapy, particularly if topical, could have obvious implications for the treatment of vURI and the prevention of complications such as acute otitis media.
Viral modification of Inflammatory Response Increasing its Virulence
Specific viral infections have been shown to increase the chance and virulence of bacterial infections [23]. Whereas the biology is not completely understood, viral and bacterial synergism has been theorized to be secondary to viral damage to host cells, local immunomodulation, and changes in the local environment that render the host fertile for bacterial infection [20]. Synergism has been identified in vURI and otitis media. Respiratory syncytial virus is a well-known cause of respiratory tract infections and has been strongly associated with acute otitis media [24–26]. A high RSV viral load is associated with an increased odds ratio of Streptococcus pneumonia and Haemophilus influenzae acute otitis media. Recently, data have implicated special mechanisms that allow RSV induction of proinflammatory cytokines that cause immune modulation and downregulation of IFN-γ [27]. It is theoretical, but quite possible, that immune modulation and dysfunction such as this determine the risk of developing otitis media.
Cytokine Response, Upper Respiratory Infection, and Otitis Media
Cytokine response in vURTI has also been correlated to the development of acute otitis media [28]. Patel et al. [25] determined that an elevated nasopharyngeal IL-1β concentration correlated with an increased risk of acute otitis media. Correlating this data with that of the Down syndrome study, it is possible that the predisposition to otitis media seen in Down syndrome is related to the cytokine response in addition to Eustachian tube dysfunction. If cytokines were associated with the risk of otitis media, one would think that a reduction in cytokine response could achieve decreased rates of otitis. Heinonen et al. found that treatment (oseltamivir) of influenza A within 24 h of onset significantly reduced the time to resolution from 6.5 to 3 days [29•]. Interestingly, treatment within 12 h, but not 24 h, correlated with an 85 % decreased incidence of acute otitis media. How this drug resulted in a decreased rate of acute otitis media is not known, but one could make an argument that reduction of the initial proinflammatory cytokines is central to this biologic effect.
Cytokines and Otitis Media
Much time and effort has been spent evaluating the role of cytokines in otitis media throughout the years [30]. Cytokines can be released from numerous cell types found within the middle ear cleft including epithelial, endothelial, and immune cells of all types. Over the past year and a half, a few studies were published that increased our collective knowledge of the various cytokines present in otitis media. Other studies have helped to characterize the cytokines involved in specific types of conditions that may contribute to otitis media.
Tumor necrosis factor (TNFA, formerly known as TNFα) and its role in otitis media have been well documented [31]. TNFA causes the release of other inflammatory cytokines and is one of the most potent inducers of inflammation in otitis media. It is often found in high concentrations of middle ear effusions and is capable of creating otitis media with effusion independent of an infectious state [32, 33]. Moreover, TNFA expressed in higher concentrations is associated with an increased frequency and duration of otitis media [34, 35]. Despite these negative effects of TNFA, its absence (TNFA deficient mice) is associated with prolonged duration and inability to eradicate bacteria from the middle ear [36]. Coupling this fact with the fact that TNFA has the profound ability to induce apoptosis [37, 38], Ebmeyer et al. sought to identify the role of TNF-mediated apoptosis during otitis media [39•]. They used a mouse model and compared wild-type to TNFA deficient mice after inducing experimental otitis media using nontypeable H. influenza. They showed that epithelial and stromal thickness was significantly greater in the untreated state and after day 5 when the wild-type mice started to show recovery of middle ear cells. Furthermore, the TNFA knockouts developed polyps in a much higher proportion compared to wild-type mice. Lastly, the rate of apoptosis was assessed, and there was a delay of 2 days to peak apoptosis in the TNFA-deficient mice. Overall, this study indicates that TNFA is critical for cell turnover in healthy and diseased states, in addition to its widely known inflammatory effects.
Vascular endothelial growth factor (VEGF) increases vascular permeability greatly (5 × 104 × histamine) [40]. VEGF production is stimulated by hypoxia, endotoxin, and TNF-α [41]. Recombinant VEGF (rVEGF) experimentally produces middle ear effusion, cellular infiltration, subepithelial edema, and vascular dilation [42]. With this is mind, Sekiyama et al. analyzed the middle ear effusions of 33 children for the presence of VEGF, IL-8, endotoxin concentration, and albumin levels [43•]. This study determined that VEGF, albumin, IL-8, and endotoxin were present in 100 %, 100 %, 98 %, and 89 %, respectively, of the 46 effusions. Comparing mucoid versus serous effusions, VEGF, IL-8, and endotoxin concentrations were significantly greater. Analyzing the concentrations within each class of effusion found VEGF to be correlated to endotoxin and albumin only within the mucoid effusions. Albumin is not produced in the middle ear and VEGF concentrations are much lower in the serum, allowing the correlation in mucoid effusions to be a rational conclusion. The fact that they are not correlated in serous effusions seems to be contradictory; however, other mediators of vascular permeability, such as histamine, platelet-activating factor, and other inflammatory products, must be considered. Overall, this study suggests that endotoxins can directly stimulate VEGF production and subsequently mucoid middle ear effusion.
Cytokine Response in Inner Ear Inflammation Associated with Otitis Media
As can be expected, much research has been performed on the cytokine response in otitis media and specifically the response in the middle ear. With otitis media, the inner ear is also subject to inflammation. As stated earlier, chronic otitis media can cause tissue remodeling and deleterious consequences including sensorineural hearing loss, speech delay, and learning difficulties. This tissue remodeling also occurs in the inner ear, causing decreased inner ear hair cells, spiral ganglion cells, accumulation of perilymphatic inflammatory cells, and scarring of the stria vascularis and spiral ligament [44]. These inner ear processes are caused by diffusion of cytokines through the round window and by intracochlear inflammatory responses to middle ear pathogens [45, 46]. To further our understanding of the inner ear inflammatory response, MacArthur et al. investigated middle ear and cochlear cytokine gene expression in both AOM and COM using separate mouse models for each [47••]. This investigation included analysis of both inflammatory and tissue remodeling cytokines. The acute otitis media model resulted in significant middle ear expression of IL-1α, IL-1β, IL-6, and less potent production of TNF-α and BMP7. The acute otitis media model resulted in significant inner ear expression of IL-1α, IL-1β, IL-6, TNF-α, TGFβ 3, and VEGFα.
In the chronic otitis media model, the expression of middle ear cytokines was significant for an 18-fold increase in IL-1α, 44-fold increase in IL-1β, and 4-fold increases in TNF-α and VEGFα, while the remodeling cytokines of BMP6, BMP7, FGF1, and FGF3 were decreased. The expression of inner ear cytokines showed more upregulation affecting IL-1α, IL-1β, IL-2, IL-6, TNF-α, TGFβ 3, and VEGFα, as well as BMP7 and FGF1. The cytokine expression in the chronic condition was significantly elevated compared to the acute otitis media in both middle and inner ear profiles. This study is significant as it provides evidence (and quantifies it) that direct gene expression occurs in cochlear tissue secondary to otitis media for the first time [44]. It is also important that this occurs in a number of inflammatory and tissue-remodeling cytokines, which can have obvious implications in end organ damage resulting in sensorineural hearing loss. What this study does not reveal is the mechanism of how cochlear tissues communicate with the middle ear. Does cochlear gene expression occur because of the bacterial components, or is it due to inflammatory molecules crossing the round window, or both?
Cytokines and Ion Transport
Throughout living organisms, ion and water transport is essential for proper function. Ion and water transport is vital to middle ear homeostasis, as shown in studies suggesting active roles for epithelial sodium channels and aquaporins [48, 49]. Additionally, IL-1β suppresses the epithelial sodium channel and sodium channel-dependent fluid absorption in middle ear cells [50]. MacArthur et al. recently published their work determining the relationship between inflammatory gene expression in acute otitis media and various ion homeostasis genes within the middle ear [51••]. Their experimental model demonstrated significant upregulation of inflammatory genes and concomitant downregulation of most ion homeostasis genes studied, including aquaphorins 1, 2, and 5, Na+K+ATPases, claudins (Cldn3a), gap junction beta-6 (GJB6), epithelial sodium channel (ENaC), and K+ ion transport channel [48]. This suggests that downregulation of many ion transport genes may be critical to understanding the pathopysiology of middle ear fluid accumulation during otitis media. Further studies would be helpful to determine how and when upregulation of ion homeostasis genes occurs with relationship to the decreasing inflammatory response. Future therapeutic options may exist, and whether therapeutic upregulation of ion homeostatic genes can be created as a treatment of chronic otitis media needs to be determined.
Cytokine Response to Bacteria and Bacterial Products in Otitis Media
Middle ear inflammation and cytokine expression in middle ear effusion are often correlated with bacterial infection, while others support a viral etiology for the release of cytokines. Recently, Stol et al. added to this body of literature by evaluating middle ear fluid in 116 patients (ages 5 and under) undergoing tympanostomy tube insertion [52]. They used quantitative PCR techniques to isolate various bacteria (Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis) and 15 respiratory viruses from middle ear fluid. Additionally, they determined the concentrations of IL-1β, IL-6, IL-8, IL-10, IL-17a, and TNF-á. The patients were grouped by presence of bacteria (27 %), virus (28 %), both (27 %), or neither (19 %) in the middle ear fluid. A significantly higher concentration of IL-1β, IL-6, IL-8, and IL-10 was identified in middle ears containing bacteria, virus, and neither virus nor bacteria. Recurrent and chronic otitis media levels of cytokines were similar as well. The concentrations of various cytokines were tabulated against the PCR results. Within the middle ears that were positive for bacteria, H. influenzae had significantly more cytokines than M. catarrhalis and S. pneumoniae.
Overall, these results suggest the presence of bacteria or bacterial components is associated with a greater concentration of cytokines than viruses in subjects who are not actively infected. This may have significance in chronic otitis media; however, this study has limitations. The study did not evaluate the duration of the effusion or duration since the last acute infection. The presence of bacteria could represent a more recent acute infection, which would be associated with higher levels of cytokines that are in the process of declining. Thus, it is just as likely that the significant difference seen in this study was associated with the duration since the last acute infection.
The importance of bacteria and the inflammatory response they incite was evaluated in another recent study by Lee et al. [53]. This study identified cytokines from the transforming growth factor (TGF) family as having a significant role in tissue remodeling. The various TGF isomers are highly regulated and are critical actors in the formation of fibrosis and granulation tissue [54]. This study evaluated the TGF-β signaling pathway occurring in a rat model of acute otitis media by inoculation with S. pneumococcus (Pn6A), nontypable H. influenza (NTHi), or eustachian tube obstruction (ETO). Pn6A and NTHi, to a much larger extent, increased the TGF pathway activity, whereas controls and ETO did not. Not insignificantly, the increased activity induced by NTHi was associated with an increased proliferation of the middle ear submucosal layer compared to both control and Pn6A. ETO produced results similar to those in controls, suggesting that eustachian tube dysfunction does not cause the proliferation of granulation tissue or subsequent fibrosis without bacterial infection.
Cytokine Production Due to Lipopolysaccharide (LPS)-Induced Otitis Media
Lipopolysaccharides are components of the outer membrane of gram-negative bacteria and have been isolated in middle ear effusions. They are known to incite significant inflammation. LPS has been shown to produce IL-1β, IL-6, TNF-α, COX-1, and COX-2 in the middle ear [27, 55, 56]. As such, it has been used in numerous studies to induce experimental otitis media [57–59]. What is not known is how LPS induces inflammation. Eguchi et al. investigated LPS-induced cytokine production using a mouse model [60•]. They showed that when using prostaglandin D2 receptor (DP) knockout mice, LPS induced less production of IL-1β, IL-6, and macrophage inflammatory protein (MIP)-2 (murine functional homologue to IL-8). Additionally, they demonstrated that individual administration of PGD2 stimulates IL-1β, IL-6, and MIP-2. They hypothesized that these data suggest a role for DP receptor antagonists as a therapeutic option in otitis media as their results suggest that LPS induces inflammation via DP [57].
Cytokine Production and Extraesophageal Reflux-Induced Otitis Media
Extraesophageal reflux has been implicated in many diseases of the aerodigestive tract, including asthma, laryngomalacia, chronic laryngitis, chronic sinusitis, and otitis media [61]. Pepsin has been identified in middle ear effusions [62]. Moreover, the pepsin concentration within the middle ear has been correlated to pharyngeal reflux episodes recorded during dual-probe pH monitoring [63]. Başoğlu et al. assessed the cytokine expression in gastric-content-induced middle ear inflammation [64]. They used a rabbit model and exposed the middle ear to the rabbit’s own gastric contents via a myringotomy. They analyzed the presence of numerous cytokines via immunohistochemistry. They found significant increases in VEGF, inducible nitric oxide synthase (iNOS), endothelial nitric oxide synthase (eNOS), IL-1β, and IL-17, implicating these cytokines as possible effectors of middle ear inflammation secondary to gastric reflux. IL-1β is well known as a proinflammatory mediator elevated in otitis media. IL-17 is also a proinflammatory cytokine; however, its other roles are to generate Th1 responses and to provide immunity against some intracellular pathogens. To summarize, this study attempts to identify cytokine induction created by gastric content exposure. As expected, gastric contents do cause inflammation, but it is unknown if the amount of gastric exposure assessed is representative of the actual pathophysiology. Another related concern involves the presence of pepsin alone. While gastric contents create damage, it is imperative to determine whether nonacid pepsin is capable of inducing inflammation and whether the pepsin identified in middle ear effusions is no longer exposed to a low enough concentration to be effective.
Cytokine Production in Chronic Otitis Media
Chronic middle ear inflammation with and without cholesteatoma is associated with tissue remodeling that can induce pathological changes within the middle ear space. Kuczkowski et al. performed a prospective study assessing the relationship between TNF-α, Il-1, IL-6, and IL-10 and the degree of bone destruction and level of invasion in patients with COM with and without cholesteatoma [65]. IL-10 was identified as being 5.6 and 2.6 fold greater in granulation tissue than in normal skin and cholesteatoma, respectively. The cholesteatoma expressed higher amounts of TNF-α, IL-1, and IL-6, whereas normal skin and granulation tissue showed no significant differences in these cytokines. There also was a strong inverse correlation between the IL-10 level and bone destruction and degree of invasion, suggesting a beneficial effect of IL-10. IL-10 was negatively correlated to TNF-α and IL-6. Perhaps most interestingly, however, TNF-α, IL-1, and IL-6 increased in proportion to the degree of bone destruction and invasion, confirming other studies that support their role in osteoclastic activity.
Chronic otitis media exerts its effects through pathological changes of neovascularization, sclerosis, and osteoclastogenesis. In a recent study by Sautter et al. [66•], bone morphogenic protein (BMP is known to regulate osteoblastic and osteoclastic activity), fibroblast growth factor (FGF), and matrix metalloproteinases (MMP) were evaluated in an acute otitis media mouse model at various time points (1, 3, 5, and 7 days after inoculation with heat-killed S. pneumoniae). Their results revealed significant downregulation of various tissue remodeling cytokines (BMP and FGF) and upregulation of some members of the MMP family. Specifically, BMP 3, 4, 6, and 8a were downregulated. BMP 1 and 7 were mildly upregulated. FGF 3, 6, and r1 were downregulated, whereas MMP 2, 3, and 9 were upregulated [63]. The upregulation of MMP 2, 3, and 9 is consistent with previous studies identifying greater concentrations in mucoid middle ear effusions [67]. At this point, the specific importance of the initial downregulation of BMP and FGF family cytokines during the acute phase is not known. Conceivably, their downregulation is part of the complex interaction of molecular mediators involved in acute and chronic otitis media. Future research into the interplay between the inflammatory and tissue remodeling cytokines may provide further insight into the pathogenesis of otitis media and may offer novel ways to affect the outcome of otitis media.
Cytokine Gene Polymorphisms and Otitis Media
Historically, acute otitis media has been recognized as having high heritability [68–70]. Cytokine polymorphisms have predicted susceptibility to otitis media and the severity of respiratory syncytial viral infection [71, 72]. Additionally, the frequency of otitis media has also been correlated to cytokine polymorphisms of TNFα, IL-10, IL-6, and IFN-ϒ [73]. McCormick et al. recently reported a prospective longitudinal study evaluating the role of cytokine polymorphisms (TNFα-308, IL-6-174, and IL-1β+3953) and environmental risk factors for acute otitis media severity in 128 subjects [74•]. They determined that disease severity was more strongly associated with tobacco smoke exposure, young age, and family history than any of the specific cytokine polymorphisms they were assessing. They did find, however, that in a subset with more severe tympanic membrane inflammation, IL-1β+3953 was more predictive. The fact that family history was the most significantly correlated risk factor is interesting in that it corroborates the heritability of otitis media. The lack of a significant correlation between cytokine polymorphism and acute otitis media overall implies that none exists or that the polymorphisms studied were not associated with otitis media severity of illness. It could also be the case that the disease severity is multifactorial and that family history can group many risk factors together by putting certain anatomic and molecular risks in the same cohort. Overall, this study affirms the multifactorial susceptibility of acute otitis media.
To further explore the genetics of inflammation, Rye et al. assessed sma- and Mad-related (SMAD) genes of the TGFβ pathway and single-nucleotide polymorphisms (SNPs) within FBXO11 and EVI1 families and their relationship to recurrent acute otitis media or chronic otitis media with effusion in western Australians [75]. Based on studies in mice using Fbxo11, it is believed that the human analog FBXO11 is also involved in the TGFβ signaling pathway [76]. Their results identified FBXO11 as being highly associated with recurrent acute otitis media and chronic otitis media. Interestingly, the single most associated SNP (rs330787) of FBXO11 that was associated with otitis media severity in this study was not associated with otitis media in the Minnesota COME/ROM family study [77].
The association of otitis media with numerous genetic variants of genes regulating cytokines offers many possibilities for future research. Learning the genetic polymorphisms of cytokines can also allow further understanding of the implications of cytokine manipulation and the subsequent effects on inflammatory and immune reactions to disease.
Conclusions
Cytokine responses in the common cold and otitis media are integral to understanding the molecular and cellular mechanisms of these diseases. Viruses causing illness in the upper respiratory tract are inextricably linked to otitis media. Within otitis media, understanding the varied effects of cytokine responses may help unlock some of the intracellular intricacies that will eventually allow better therapies for both acute and chronic otitis media.
Acknowledgment
Dr. Alper has received grant support from the National Institutes of Health.
Disclosure
No potential conflicts of interest relevant to this article were reported.
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.Alper CM, Doyle WJ, Winther B, Hendley JO. Upper respiratory virus detection without parent-reported illness in children is virus-specific. J Clin Virology. 2008;42:120–122. doi: 10.1016/j.jcv.2008.04.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Makela MJ, Puhakka T, Ruuskanen O, et al. Viruses and bacteria in the etiology of the common cold. J Clin Microbiol. 1998;36(2):539. doi: 10.1128/jcm.36.2.539-542.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Ruohola A, Meurman O, Nikkari S, et al. Microbiology of acute otitis media in children with tympanostomy tubes: prevalence of bacteria and virus. Clin Infect Dis. 2006;43:1417–1422. doi: 10.1086/509332. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Song J, Jin Y, Xie Z, et al. Novel human bocavirus in children with acute respiratory tract infection. Emerg Infect Dis. 2010;16:324–327. doi: 10.3201/eid1602.090553. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Suzuki A, Watanabe O, Okamoto M et al. Detection of human metapneumovirus from children with acute otitis media. Pediatr Infect Dis;2005:655–57. [DOI] [PubMed]
- 6.Winther B, Alper CM, Mandel EM, et al. Temporal relationships between colds, upper respiratory viruses detected by polymerase chain reaction, and otitis media in young children followed through a typical cold season. Pediatrics. 2007;119:1069–1075. doi: 10.1542/peds.2006-3294. [DOI] [PubMed] [Google Scholar]
- 7.Fendrick AM, Monto AS, Nightengale B, Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med. 2003;163:487–494. doi: 10.1001/archinte.163.4.487. [DOI] [PubMed] [Google Scholar]
- 8.Klein JO. The burden of otitis media. Vaccine. 2000;19(Supp 1):S2–S8. doi: 10.1016/S0264-410X(00)00271-1. [DOI] [PubMed] [Google Scholar]
- 9.Gonzales R, Malone DC, Maselli JH, Sande MA. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis. 2001;33:757–762. doi: 10.1086/322627. [DOI] [PubMed] [Google Scholar]
- 10.Noah TL, Henderson FW, Wortman IA, et al. Nasal cytokine production in viral acute upper respiratory infection of childhood. J Infect Dis. 1995;171(3):584–592. doi: 10.1093/infdis/171.3.584. [DOI] [PubMed] [Google Scholar]
- 11.Röseler S, Holtappels G, Wagenmann M, Bachert C. Elevated levels of interleukins IL-1 beta, IL-6, and IL-8 in naturally acquired viral rhinitis. Eur Arch Otorhinolaryngol. 1995;252(suppl 1):S61–S63. doi: 10.1007/BF02484437. [DOI] [PubMed] [Google Scholar]
- 12.Laham FR, Israele V, Casellas JM, et al. Differential production of inflammatory cytokines in primary infection with human metapneumonvirus and with other common respiratory viruses of infancy. J Infect Dis. 2004;189(11):2047–2056. doi: 10.1086/383350. [DOI] [PubMed] [Google Scholar]
- 13.Kaiser L, Fritz RS, Straus SE, et al. Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses. J Med Virol. 2001;64(3):262–268. doi: 10.1002/jmv.1045. [DOI] [PubMed] [Google Scholar]
- 14.Noah TL, Ivins SS, Murphy P, et al. Chemokines and inflammation in the nasal passages of infants with respiratory syncytial virus bronchiolitis. Clin Immunol. 2002;104(1):86–95. doi: 10.1006/clim.2002.5248. [DOI] [PubMed] [Google Scholar]
- 15.Oh JW, Lee HB, Park IK, Kang JO. Interleukin-6, interleukin-8, interleukin-11, and interferon-gamma levels in nasopharyngeal aspirates from wheezing children with respiratory syncytial virus or influenza A virus infection. Pediatr Allergy Immunol. 2002;13(5):350–356. doi: 10.1034/j.1399-3038.2002.02018.x. [DOI] [PubMed] [Google Scholar]
- 16.Garofalo RP, Hintz KH, Hill V, et al. Production of interferon gamma in respiratory syncytial virus infection of humans is not associated with interleukins 12 and 18. J Med Virol. 2004;73(2):289–294. doi: 10.1002/jmv.20089. [DOI] [PubMed] [Google Scholar]
- 17.Revai K, Petal JA, Grady JJ, et al. Association between cytokine gene polymorphisms and risk for upper respiratory tract infection and acute otitis media. Clin Infect Dis. 2009;49(2):257–261. doi: 10.1086/599833. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Gentile DA, Doyle WJ, Zeevi A, Howe-Adams J, Kapadia S, Trecki J, et al. Cytokine gene polymorphisms moderate illness severity in infants with respiratory syncytial virus infection. Hum Immunol. 2003;64(3):338–344. doi: 10.1016/S0198-8859(02)00827-3. [DOI] [PubMed] [Google Scholar]
- 19.Broers CJ, Gemke RJBJ, Wigerman ME, et al. Increased pro-inflammatory cytokine production in Down syndrome children upon stimulation with live influenza A virus. J Clin Immunol. 2012;32:323–329. doi: 10.1007/s10875-011-9625-4. [DOI] [PubMed] [Google Scholar]
- 20.Cohen S, Janicki-Deverts D, Mller G. Psychological stress and disease. JAMA. 2007;298(14):1685–1687. doi: 10.1001/jama.298.14.1685. [DOI] [PubMed] [Google Scholar]
- 21.Cohen S, Janicki-Deverts D, Doyle WJ, et al. Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk. PNAS. 2012;109(16):5995–5999. doi: 10.1073/pnas.1118355109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Pinto R, Herold S, Cakarova L, Hoegner K, Lohmeyer J, Planz O, et al. Inhibition of influenza virus-induced NF-kappaB and raf/MEK/ERK activation can reduce both virus titers and cytokine expression simultaneously in vitro and in vivo. Antiviral Res. 2011;92(1):45–56. doi: 10.1016/j.antiviral.2011.05.009. [DOI] [PubMed] [Google Scholar]
- 23.McCullers JA. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev. 2006;19(3):571–582. doi: 10.1128/CMR.00058-05. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Patel JA, Nguyen DT, Reval K, Chonmaitree T. Role of respiratory syncytial virus in acute otits media: implications for vaccine development. Vaccine. 2007;25:1683–1689. doi: 10.1016/j.vaccine.2006.10.045. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Chonmaitree T, Revai K, Grady JJ, et al. Viral upper respiratory tract infection and otitis media complication in young children. Clin Infect Dis. 2008;46(6):815–823. doi: 10.1086/528685. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Henderson FW, Collier AM, Sanyal MA, et al. A longitudinal study of respiratory viruses and bacteria in the etiology of acute otitis media with effusion. NEJM. 1982;306:1377–1383. doi: 10.1056/NEJM198206103062301. [DOI] [PubMed] [Google Scholar]
- 27.Bueno SM, Gonzalez PA, Riedel CA, et al. Local cytokine response upon respiratory syncytial virus infection. Immunol Lett. 2011;136(2):122–129. doi: 10.1016/j.imlet.2010.12.003. [DOI] [PubMed] [Google Scholar]
- 28.Patel JA, Nair S, Revai K, Grady J, Chonmaitree T. Nasopharyngeal acute phase cytokines in viral upper respiratory infection: impact on acute otitis media in children. Pediatr Infect Dis J. 2009;28(11):1002–1007. doi: 10.1097/INF.0b013e3181aa5b13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Heinonen S, Silvennoinen H, Lehtinen P, et al. Early oseltamivir treatment of influenza in children 1–3 years of age: a randomized controlled trial. Clin Infect Dis. 2010;51(8):887–894. doi: 10.1086/656408. [DOI] [PubMed] [Google Scholar]
- 30.Juhn SK, Jung MK, Hoffman MD, Drew BR, Preciado DA, Sausen NJ, et al. The role of inflammatory mediators in the pathogenesis of otitis media and sequelae. Clin Exp Otorhinolaryngol. 2008;1(3):117–138. doi: 10.3342/ceo.2008.1.3.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Ophir D, Hahn T, Schattner A, Wallach D, Aviel A. Tumor necrosis factor in middle ear effusions. Arch Otolaryngol Head Nec Surg. 1988;114(11):1256–1258. doi: 10.1001/archotol.1988.01860230050021. [DOI] [PubMed] [Google Scholar]
- 32.Skotnicka B, Hassmann E. Cytokines in children with otitis media with effusion. Eur Arch Otorhinolaryngol. 2000;257:323–326. doi: 10.1007/s004059900218. [DOI] [PubMed] [Google Scholar]
- 33.Catanzaro A, Ryan A, Bather S, Wasserman SI. The response to human rIL-1, rIL-2, and rTNF in the middle ear of guinea pigs. Laryngoscope. 1991;101:271–275. doi: 10.1288/00005537-199103000-00008. [DOI] [PubMed] [Google Scholar]
- 34.Maxwell K, Leonard G, Kreutzer DL. Cytokine expression in otitis media with effusion. Tumor necrosis factor soluble receptor. Arch Otolaryngol Head Neck Surg. 1997;123:984–988. doi: 10.1001/archotol.1997.01900090100015. [DOI] [PubMed] [Google Scholar]
- 35.Nell MJ, Grote JJ. Endotoxin and tumor necrosis factor-alpha in middle ear effusions in relation to upper airway infection. Laryngoscope. 1999;109:1815–1819. doi: 10.1097/00005537-199911000-00017. [DOI] [PubMed] [Google Scholar]
- 36.Leichtle A, Henandez M, Ebmeyer J, et al. CC chemokine ligand 3 overcomes the bacteriocidal and phagocytic defect of macrophages and hastens recovery from experimental otitis media in TNF−/− mice. J Immunol. 2010;184:3087–3097. doi: 10.4049/jimmunol.0901167. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Chen G, Goeddel DV. TNF-R1 signaling: a beautiful pathway. Science. 2002;296:1634–1635. doi: 10.1126/science.1071924. [DOI] [PubMed] [Google Scholar]
- 38.Mathew SJ, Haubert D, Krönke M, Leptin M. Looking beyond death: a morphogenetic role for the TNF signaling pathway. J Cell Sci. 2009;122:1939–1946. doi: 10.1242/jcs.044487. [DOI] [PubMed] [Google Scholar]
- 39.Ebmeyer J, Leichtle A, Hernandez M, et al. TNFA deletion alters apoptosis as well as caspase 3 and 4 expression during otitis media. BMC Immunol. 2011;12:12. doi: 10.1186/1471-2172-12-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Connolly DT, Jeuvelman DM, Nelson R, et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest. 1989;84:1470–1478. doi: 10.1172/JCI114322. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Sun D, Matsune S, Ohori J, et al. TNF-alpha and endotoxin increase hypoxia-induced VEGF production by cultured human nasal fibroblasts in synergistic fashion. Auris Nasus Larynx. 2005;32:243–249. doi: 10.1016/j.anl.2005.01.004. [DOI] [PubMed] [Google Scholar]
- 42.Kim TH, Chae SW, Kim HJ, Jung HH. Effect of recombinant vascular endothelial growth factor on experimental otitis media with effusion. Acta Otolaryngol. 2005;125:256–259. doi: 10.1080/00016480410024677. [DOI] [PubMed] [Google Scholar]
- 43.Sekiyama K, Ohori J, Matsune S, Kurono Y. The role of vascular endothelial growth factor in pediatric otitis media with effusion. Auris Nasus Larynx. 2011;38(3):319–324. doi: 10.1016/j.anl.2010.10.008. [DOI] [PubMed] [Google Scholar]
- 44.Cureoglu S, Schachern P, Rinaldo A, et al. Round window membrane and labyrinthine pathological changes: an overview. Acta Otolaryngol. 2005;125:9–15. doi: 10.1080/00016480410022534. [DOI] [PubMed] [Google Scholar]
- 45.Schachern P, Tsuprun V, Cureoglu S, et al. The round window membrane in otitis media: effect of pneumococcal proteins. Arch Otolaryngol Head Neck Surg. 2008;134:658–662. doi: 10.1001/archotol.134.6.658. [DOI] [PubMed] [Google Scholar]
- 46.Moon S, Woo J-I, Lee H-Y, et al. Toll-like receptor 2-dependent NF-kappaB activation is involved in nontypeable Haemophilus influenza-induced monocyte chemotactic protein 1 up-regulation in the spiral ligament fibrocytes of the inner ear. Infect Immun. 2007;75:3361–3372. doi: 10.1128/IAI.01886-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.MacArthur CJ, Pillers DA, Pang J, Kempton JB, Trune DR. Altered expression of middle and inner ear cytokines in mouse otitis media. Laryngoscope. 2011;121(2):365–371. doi: 10.1002/lary.21349. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Son EJ, Kim SH, Park HY, et al. Activation of epithelial sodium channel in human idle ear epithelial cells by dexamethasone. Eur J Pharmacol. 2009;602:383–387. doi: 10.1016/j.ejphar.2008.11.012. [DOI] [PubMed] [Google Scholar]
- 49.Zhang Q, Liu C, Wang J, et al. Expression pattern of aquaporin 4 and 5 in the middle ear of guinea pigs with secretory otitis media. Act Oto-laryngologica. 2010;130:68–74. doi: 10.3109/00016480902974183. [DOI] [PubMed] [Google Scholar]
- 50.Choi JY, Choi Y-S, Kim SJ, et al. Interleukin-1β suppresses epithelial sodium channel β-subunit expression and ENaC-dependent fluid absorption in human middle ear epithelial cells. Eur J Pharmacol. 2007;567:19–25. doi: 10.1016/j.ejphar.2007.04.026. [DOI] [PubMed] [Google Scholar]
- 51.MacArthur CJ, Hausman F, Kempton JB, Trune DR. Murine middle ear inflammation and ion homeostasis gene expression. Otol Neurotol. 2011;32(3):508–515. doi: 10.1097/MAO.0b013e31820e6de4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Stol K, Diavatopoulos DA, Graamans K, Engel JA, Melchers WJ, Savelkoul HF, et al. Inflammation in the middle ear of children with recurrent or chronic otitis media is associated with bacterial load. Pediatr Infect Dis J.; 2012, Jun 4. [DOI] [PubMed]
- 53.Lee YW, Chung Y, Juhn SK, Kim Y, Lin J. Activation of the transforming growth factor beta pathway in bacterial otitis media. Ann Otol Rhinol Laryngol. 2011;120(3):204–213. doi: 10.1177/000348941112000310. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Cooter MS, Eisma RJ, Burleson JA, et al. Transforming growth factor-beta expression in otitis media with effusion. Laryngoscope. 1998;108(7):1066–1070. doi: 10.1097/00005537-199807000-00021. [DOI] [PubMed] [Google Scholar]
- 55.Cho JG, Lee ES, Wo JS, et al. Expressions of cyclooxygenase 1 and 2 in endotoxin-induced otitis media with effusion in the rat. Int J Pediatr Otorhinolaryngol. 2007;71:101–106. doi: 10.1016/j.ijporl.2006.09.010. [DOI] [PubMed] [Google Scholar]
- 56.Kariya S, Schacher PA, Cureoglu S, et al. Up-regulation of macrophage migration inhibitory factor induced by endotoxin in experimental otitis media with effusion in mice. Acta Otolaryngol. 2008;128:750–755. doi: 10.1080/00016480701714228. [DOI] [PubMed] [Google Scholar]
- 57.Dattaray P, Pudrith C, Nyc MA, et al. Effect of ciprofloxacin/dexamethasone versus ciprofloxacin/hydrocortisone on lipopolysaccharide-induced experimental otitis media. Otolaryngol Head Neck Surg. 2011;145:288–294. doi: 10.1177/0194599811403868. [DOI] [PubMed] [Google Scholar]
- 58.Song J, Kwon SK, Cho CG, et al. Microarray analysis of microRNA expression in LPS induced inflammation of the human middle ear epithelial cells (HMEECs) Int J Pediatr Otorhinolaryngol. 2011;75:648–651. doi: 10.1016/j.ijporl.2011.02.001. [DOI] [PubMed] [Google Scholar]
- 59.Pudrith C, Martin D, Kim YH, et al. Glucocorticoids reduce nitric oxide concentration in middle ear effusion from lipopolysaccharide induced otitis media. Int J Pediatr Otorhinolaryngol. 2010;74:384–386. doi: 10.1016/j.ijporl.2010.01.008. [DOI] [PubMed] [Google Scholar]
- 60.Eguchi M, Kariya S, Okano M, Higaki T, Makihara S, Fujiwara T, et al. Lipopolysaccharide induces proinflammatory cytokines and chemokines in experimental otitis media through the prostaglandin D2 receptor (DP)-dependent pathway. Clin Exp Immunol. 2011;163(2):260–269. doi: 10.1111/j.1365-2249.2010.04292.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Schreiber S, Garten D, Sudhoff H. Pathophysiological mechanisms of extraesophageal reflux in otolaryngeal disorders. Eur Arch Otorhinolaryngol. 2009;266:17–24. doi: 10.1007/s00405-008-0770-1. [DOI] [PubMed] [Google Scholar]
- 62.Tasker A, Dettmar PW, Panetti M, et al. Is gastric reflux a cause of otitis media with effusion in children? Laryngoscope. 2002;112:1930–1934. doi: 10.1097/00005537-200211000-00004. [DOI] [PubMed] [Google Scholar]
- 63.Abd El-Fattah AM, Abdul Maksoud GA, Ramadan AS, et al. Pepsin assay: a marker for reflux in pediatric glue ear. Otolaryngol Head Neck Surg. 2007;136:464–470. doi: 10.1016/j.otohns.2006.08.030. [DOI] [PubMed] [Google Scholar]
- 64.Başoğlu MS, Eren E, Aslan H, Kolatan HE, Ozbay C, Inan S, et al. Increased expression of VEGF, iNOS, IL-1β, and IL-17 in a rabbit model of gastric content-induced middle ear inflammation. Int J Pediatr Otorhinolaryngol. 2012;76(1):64–69. doi: 10.1016/j.ijporl.2011.10.001. [DOI] [PubMed] [Google Scholar]
- 65.Kuczkowski J, Sakowicz-Burkiewicz M, Iżycka-Świeszewska E, Mikaszewski B, Pawełczyk T. Expression of tumor necrosis factor-α, interleukin-1α, interleukin-6 and interleukin-10 in chronic otitis media with bone osteolysis. ORL J Otorhinolaryngol Relat Spec. 2011;73(2):93–99. doi: 10.1159/000323831. [DOI] [PubMed] [Google Scholar]
- 66.Sautter NB, Delaney KL, Hausman FA, Trune DR. Tissue remodeling in the acute otitis media mouse model. Int J Pediatr Otorhinolaryngol. 2011;75(11):1368–1371. doi: 10.1016/j.ijporl.2011.07.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Jennings CR, Guo L, Collins HM, Birchall JP. Matrix metalloproteinases 2 and 9 in otitis media with effusion. Clin Otolaryngol. 2001;26:491–494. doi: 10.1046/j.1365-2273.2001.00510.x. [DOI] [PubMed] [Google Scholar]
- 68.Kvaerner KJ, Tambs K, Harris JR, et al. Distribution and heritability of recurrent ear infections. Ann Otol Rhinol Laryngol. 1997;106:624–632. doi: 10.1177/000348949710600802. [DOI] [PubMed] [Google Scholar]
- 69.Casselbrant ML, Mandel EM, Fall PA, et al. The heritability of otitis media: a twin and triplet study. JAMA. 1999;282:2125–2130. doi: 10.1001/jama.282.22.2125. [DOI] [PubMed] [Google Scholar]
- 70.Casselbrant ML, Mandel EM, Rockett HE, et al. The genetic component of middle ear disease in the first 5 years of life. Arch Otolaryngol Head Neck Surg. 2004;130:273–278. doi: 10.1001/archotol.130.3.273. [DOI] [PubMed] [Google Scholar]
- 71.Emonts M, Veenhoven RH, Wiertsema SP, et al. Genetic polymorphisms in immunoresponse genes TNFA, IL6, IL10, and TLR4 are associated with recurrent acute otitis media. Pediatrics. 2007;120:814–823. doi: 10.1542/peds.2007-0524. [DOI] [PubMed] [Google Scholar]
- 72.Gentile DA, Doyle WJ, Zeevi A, et al. Cytokine gene polymorphisms moderate illness severity in infants with respiratory syncytial virus infection. Hum Immunol. 2003;64:338–344. doi: 10.1016/S0198-8859(02)00827-3. [DOI] [PubMed] [Google Scholar]
- 73.Alper CM, Winther B, Hendley JO, Doyle WJ. Cytokine polymorphisms predict the frequency of otitis media as a complication of rhinovirus and RSV infection in children. Eur Arch Otorhinolaryngol. 2009;266:199–205. doi: 10.1007/s00405-008-0729-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.• McCormick DP, Grady JJ, Diego A, Matalon R, Revai K, Patel JA, et al. Acute otitis media severity: association with cytokine gene polymorphisms and other risk factors. Int J Pediatr Otorhinolaryngol 2011, Mar 25.This is the first study to correlate otitis media severity with environmental and genetic risk factors. [DOI] [PMC free article] [PubMed]
- 75.Rye MS, Wiertsema SP, Scaman ES, Oommen J, Sun W, Francis RW, et al. FBXO11, a regulator of the TGFβ pathway, is associated with severe otitis media in western Australian children. Genes Immun. 2011;12(5):352–359. doi: 10.1038/gene.2011.2. [DOI] [PubMed] [Google Scholar]
- 76.Tateossian H, Hardisty-Hughes R, Morse S, et al. Regulation of TGFβ signaling by Fbxo11, the gene mutated in the Jeff otitis media mouse mutant. Pathogenetics. 2009;2:5. doi: 10.1186/1755-8417-2-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Segade F, Daly KA, Alred D, et al. Association of the FBXO11 gene with chronic otitis media with effusion and recurrent otitis media: the Minnesota COME/ROM family study. Arch Otolaryngol Head Neck Surg. 2006;132:729–733. doi: 10.1001/archotol.132.7.729. [DOI] [PMC free article] [PubMed] [Google Scholar]